transmission dynamics and the capacity to detect and track transmission events within Australia. Recent figures indicate that 85% of adult TB cases are immigrants from high incidence countries who probably acquired their infection overseas [4, 5] . TB cases occur in highly concentrated pockets, with the highest rates reported in the 25-34 year age group [5] . Pediatric TB cases provide an important epidemiologic perspective by acting as markers of recent transmission.
Increased international travel and high rates of immigration pose major TB control challenges, especially with the global emergence of drug-resistant TB [5] [6] [7] . Among Australian born individuals, Aboriginal communities suffer a disproportionate TB disease burden [3, 5, 8] . New South Wales (NSW) reports the highest absolute patient numbers and TB incidence rates within Australia [3] , with most cases occurring in the Sydney metropolitan area, particularly within the western suburbs served by The Children's Hospital at Westmead (CHW) [5] .
Accurate assessment of the TB disease burden in children is hampered by poor case ascertainment and limited surveillance data. It is estimated that children contribute 10%-15% of the total TB disease burden in endemic areas where gross under-detection is the rule [9] . Fewer children are affected in areas like the United States [10] , western Europe [11] , and Australia [3] , due to minimal internal transmission and routine provision of post-exposure prophylaxis. In these settings, most pediatric cases occur among immigrant populations with little evidence of spillover from immigrant to resident communities [3, 12] , except in some health-and childcare-associated "outbreaks" [13] .
Apart from a few interesting case reports [14] [15] [16] [17] [18] , no comprehensive survey has been conducted to describe the clinical disease spectrum observed in children treated for TB in Australia. We aimed to describe the demographic profile, disease spectrum, and treatment response in all children treated for TB at CHW.
METHODS

Study Design and Setting
We performed a retrospective chart review of all children (<18 years) who were evaluated at CHW from January 1, 2008 through December 31, 2011 and who received TB treatment. The Children's Hospital at Westmead serves as a quaternary pediatric referral hospital for north and central NSW and some Pacific Island states; it also provides more basic services to people in its immediate vicinity. The included patients were identified from a list of infectious disease (ID) consults during this period (all TB cases are routinely referred for an ID consult).
The patients identified were cross-referenced with ICD-10 admission coding data and pharmacy medication dispensing records to ensure that all patients were enumerated. A summary of NSW TB notification data for the study period was provided by NSW TB control services.
Data Collection and Definitions
Patients were classified as microbiologically confirmed, clinically diagnosed, or "not TB." Microbiologic confirmation was established by either a positive acid-fast smear, culture, polymerase chain reaction test or suggestive histologic findings. Clinically diagnosed cases were identified at the discretion of the treating physician. Not TB cases had confirmation of an alternate diagnosis, despite initiation of TB treatment. We could only report on clinical disease characteristics recorded in the hospital notes, but all laboratory results as well as radiologic studies and reports were electronically reviewed.
Ethics permission for this audit was provided by the Royal Alexandra Hospital for Children Ethics Committee. Table 1 provides a brief summary of all TB cases reported in NSW during the study period, with detailed age break down. Approximately 5% of all TB cases in NSW occurred in the under 18 year age range. During this time, a total of 25 children were treated for TB at CHW: 15 (60%) had microbiologically confirmed TB; 7 (28%) were diagnosed on clinical grounds; and in 3 (12%), an
RESULTS
Box 1. Miliary TB With Meningitis
Eighteen-month-old boy presented with fever, stupor, and unresponsiveness; preceding history of intermittent fevers and cough for 3 months; born in Australia; parents immigrants from Afghanistan; no overseas travel or known TB exposure; entire family screened negative for TB infection; TST 0 mm; IGRA positive Communicating hydrocephalus on head CT with patchy areas of meningeal enhancement and ring-enhancing cerebellar lesions on MRI suggestive of tuberculoma; chest x-ray consistent with miliary TB; CSF pleocytosis (total white cell count 30 x 10 6 /L, protein 0.32 g/L); CSF and endotracheal aspirate PCR and culture positive for Mycobacterium tuberculosis; fully drug sensitive External ventricular drain placed without need for ventriculoperitoneal shunt; TB treatment with the addition of dexamethasone commenced; hospitalized for 4 weeks; completed 2 months of intensive phase treatment (HRZ and moxifloxacin) then 10 months HR. At 18 months from presentation; MRI normal; development normal Key points: (1) TB exposure may not be readily discernible; (2) disseminated TB occurs most commonly in young children (<2 years); (3) early correct treatment is associated with good outcome Spectrum of Disease in Children Treated for Tuberculosis 225 alternative diagnosis was established. The not TB group included 1 immunocompromised patient with confirmed Mycobacterium bovis bacille Calmette-Guérin (BCG), 1 patient with "wild type" M bovis infection, and 1 patient with Mycobacterium avium disease ( Table 2 ). The most relevant demographic and clinical details of the remaining 22 TB patients are summarized in Table 3 . A large proportion of children were immigrants or refugees (11; 50%) or had traveled to a TB-endemic country (12 of 21; 57%). However, 4 (18%) had documented contact with a potential TB source case within Australia, and 10 (45%) reported no travel outside Australia's borders in the preceding 12 months. One patient with severe disease reported no travel or TB contact history (Box 1). Table 4 includes the clinical disease profile of the 22 children diagnosed with TB. The majority (64%) reported a cough of variable character and duration. The median illness duration was 3.5 weeks but ranged from 3 days to 3 years. Malaise or lethargy (75%) and fever (73%) were the most commonly recorded symptoms, with weight loss or failure to thrive noted in 56%. Symptoms were reported in a higher percentage of microbiologically confirmed than clinically diagnosed cases. Less than 50% of patients had any discernable clinical signs on chest auscultation. Pulmonary TB cases were diagnosed on chest radiograph; the majority (10 of 16; 63%) also received a computed tomography (CT) scan to characterize the underlying pathology better. Isolated extra-thoracic disease occurred in 3 cases; 1 with miliary TB and TB meningitis (diagnosed on cerebrospinal fluid and head CT) and 2 with abdominal TB (1 diagnosed by positron emission tomography). In nonendemic areas, unusual disease manifestations may be relatively more common (Box 2).
Box 2. TB by Skin Inoculation
Twenty-three-month-old boy presented with chronic draining abdominal wound and axillary lump; visited family in India 4 months ago; born in Australia; no BCG vaccination; developed inflamed para-umbilical mass lesion; incised and drained in India; area became swollen again after return to Australia; second drainage procedure; operative bacterial culture specimens negative (no mycobacterial cultures sent); chronic draining sinus; axillary swelling had been present for 2 weeks.
TST 20 mm; abdominal wall sinus and axillary lymph node resected; both specimens PCR and culture positive for Mycobacterium tuberculosis, fully drug sensitive Completed 6 months of standard short course of TB treatment for children (HRZ for 2 months followed by HR for 4 months); initial enlargement of regional lymph nodes with eventual resolution Key points: (1) unusual TB disease manifestations do occur and may be relatively more common in nonendemic areas; (2) TB should be considered in returned travelers or immigrants from TB-endemic areas; (3) initial lymph node enlargement may occur despite adequate TB treatment Among the 15 children with microbiologically confirmed TB, 11 (73%) were culture-positive and 11 of 13 (85%) were PCR-positive. A small number (3; 20%) had visible acid-fast bacilli on microscopy. Tissue specimens were submitted for histologic evaluation in 3 cases; 2 with peripheral lymph node biopsies and 1 bone biopsy in a child with chronic dactylitis. Sputum (5 of 8) and tissue (4 of 5) specimens provided the best yield, with excellent detection by PCR compared with culture. Drug susceptibility testing was performed in the 11 culturepositive cases. No multidrug-resistant (resistance to isoniazid and rifampicin) cases were detected, but 2 demonstrated low-level (minimal inhibitory concentration ranges of 0.1-0.4 µg/ml) isoniazid resistance. Characteristic of all M bovis strains, the 2 M bovis isolates identified demonstrated pyrazinamide resistance.
The tuberculin skin test (TST) was positive (10 mm) in 16 of 20 (80%) cases. Interferon-gamma release assays (IGRAs) were positive in 13 of 15 (87%) of those tested, with discordant TST/IGRA results in 3 (23%) cases. One 15-year-old girl with TB pleural effusion (confirmed on culture) received corticosteroids; a subsequent TST test was negative (0 mm) with positive IGRA. A 13-year-old boy with a TB pleural effusion (confirmed by PCR) was TST-positive (15 mm) and IGRA-negative. The third child, a 21-month-old BCG unvaccinated boy, presented with cough and hilar adenopathy on chest radiograph 3 months after travel to China. He had a TST of 6 mm and negative IGRA, and he responded to TB treatment.
All children received directly observed therapy (DOT) of at least a 3-drug regimen consisting of isoniazid (H), rifampicin (R), and either pyrazinamide (Z) or ethambutol (E). For 1 child, moxifloxacin (M) was substituted for pyrazinamide during the intensive phase due to a cutaneous drug reaction (see Box 3) . Most children (20 of 22) received standard short course treatment of 3-4 medications during a 2-month intensive phase followed by 4 months of isoniazid and rifampicin during Box 3. Locally Transmitted TB Fifteen-year-old boy presented with 2-week cough, fever, and left-sided chest pain; Fijian background but born in Australia; friend from school diagnosed with pulmonary TB 3 months prior; TST 12 mm at initial screening but not offered preventive therapy Chest x-ray showed large left-sided pleural effusion; effusion fluid and bronchoalveolar lavage negative for Mycobacterium tuberculosis on PCR and culture Effusion drained; commenced on TB treatment; standard short course of TB treatment for adults (HRZE for 2 months followed by HR for 4 months) Developed widespread itchy, erythematous, papular rash 4 days after treatment initiation; all medications stopped; rash settled; tolerated reintroduction of single agents over 1 week; Z was not reintroduced, but moxifloxacin was added for the initial 2 months and treatment continued for a total of 9 months; chest x-ray at treatment completion demonstrated mild pleural thickening Key points: (1) TB is readily transmitted by adolescents with adult-type TB; (2) for children, the educational setting (preschool, school) and household are important sites for TB transmission; (3) adverse drug reactions are uncommon but do occur, requiring TB management expertise to adjust treatment schedules Abbreviations: BCG, bacille Calmette-Guérin; CSF, cerebrospinal fluid; CT, computed tomography; E, ethambutol; H, isoniazid; IGRA, interferon-gamma release assay; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; R, rifampicin; TB, tuberculosis; TST, tuberculin skin test; Z, pyrazinamide. the continuation phase. Only the TB meningitis (2HRZM; 10HR) and dactylitis (2HRZ; 7HR) cases received alternative regimens. Five (27%) children reported minor adverse drug effects, without any long-term sequelae. One child had nausea and vomiting, which settled after 2 weeks of uninterrupted treatment. Treatment was modified in 4 cases: 1 case had a skin rash presumptively caused by pyrazinamide; mild arthralgia resolved in 2 cases after stopping ethambutol and pyrazinamide, respectively; and 1 case had low-level transaminitis that improved on isoniazid cessation.
DISCUSSION
This case series highlights the need for ongoing vigilance to identify children with TB. It provides an overview of the clinical presentation and disease spectrum seen in an urban Australian setting. Many children were born overseas, most in Southern Asia, and nearly all had visited a TB-endemic country at some time. It is interesting to note that in only one half of the cases did the overseas exposure occur in the 12 months preceding presentation, the time window during which the vast majority of disease manifestations is expected to occur after primary M tuberculosis infection [9] . One child <5 years of age, who had household contact with a family member with TB during a trip to China, represents a missed opportunity for prevention, according to local and World Health Organization guidelines [19, 20] . Four children reported close contact with a TB source case within Australia. In the single case without any travel or TB exposure history, unrecognized exposure within the community is presumed; his parents arrived as refugees before his birth. Reducing M tuberculosis transmission to an absolute minimum within Australia's borders remains a key TB control challenge; it has also been suggested as a pragmatic marker of local TB elimination. Fever or cough with associated constitutional symptoms of greater than 2 weeks duration was the most common clinical presentation. Notable exceptions include (1) the child with dactylitis who was asymptomatic except for hand swelling for almost 3 years and (2) the child with TB meningitis who presented in coma. Despite high rates of TST and IGRA positivity, occasional false-negative results preclude their use as a reliable "rule-out" test. Interferongamma release assay sensitivity in TB disease has varied in the published studies, but it is likely to be reduced in children under 5 years [21] . False negatives have also been described in the immunosuppressed, malnourished, and those with advanced disease. The high level of TST/IGRA concordance indicates broad equivalence, which justifies the use of either test depending on practical considerations [22] [23] [24] . Chest radiographs remain the key imaging modality, but lateral images were rarely included. Lateral images are particularly helpful to assist screening for intrathoracic adenopathy [9] . The high rates of CT scans and bronchoscopies performed may not have been clinically indicated, but they reflect the broad differential diagnosis considered and reluctance to institute TB treatment in the absence of microbiologic confirmation. Microbiologic confirmation was achieved in the majority of cases with extensive sampling. Treatment was generally well tolerated and excellent outcomes were achieved, despite minor treatment adjustment in 4 cases. Compared with disease patterns from a highly endemic area [25] , the striking difference is the proportion of children from an older age range. Rather than two thirds of children being under 5 years, two thirds were older than 5 years. Pediatric TB is a marker of recent transmission [26] , so this age difference likely reflects low local M tuberculosis transmission rates in combination with the older age of children exposed outside of Australia (travel or immigration). In both settings, approximately 70% of children had isolated intrathoracic disease. The prevention of childhood TB remains a significant and achievable priority in Australia. Tuberculosis contact screening, as well as the active screening of immigrants and refugees, with the provision of prophylaxis is a key strategy. The role of BCG vaccination also requires careful consideration [27] . Bacille Calmette-Guérin is not routinely given to infants in Australia, but it is recommended for "neonates and children 5 years and under who will be traveling or living in countries or areas with a high prevalence of TB for extended periods" [28] . A broader recommendation has been made in the United Kingdom to include all children living in high prevalence areas in the United Kingdom (incidence >40/100 000) or with parents or grandparents from high prevalence countries, with or without prior TST depending on age [29] . This is in contrast to the United States where a more restrictive recommendation from the Centers for Disease Control and Prevention (endorsed by the American Academy of Pediatrics) includes only children "continually exposed to a person or people" with untreated or resistant pulmonary TB who are known to be TST negative [30] .
The study is limited by its retrospective nature. Data collection was reliant on clinical case notes, which may have contained incomplete data, and the assessment, diagnosis, and management of these cases were not controlled. The small number of cases and the selected sampling limits population inferences. However, this case series provides a valuable clinical overview demonstrating the protean "faces" of childhood TB and the need for ongoing vigilance. A more comprehensive review of pediatric TB cases throughout Australia would be informative. With timely treatment initiation, especially in very young and vulnerable children, treatment outcome is generally excellent. Specialized pediatric TB referral services provide important supportive functions, but every pediatrician should identify potential cases and refer them appropriately for further evaluation.
